Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Oberhausen

10 clinical trials in Oberhausen, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Oberhausen at a glance
10
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

10 trials in Oberhausen

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bi 1015550
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Merck Healthcare KGaA
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cemiplimab
  • Sponsor:Institut fuer Klinische Krebsforschung IKF GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:University Of Cologne
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Carbamazepine
  • Sponsor:Universitaetsklinikum Heidelberg AöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:Institut fuer Klinische Krebsforschung IKF GmbH

Systemic scleroderma

Not yet recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Lebrikizumab
  • Sponsor:Charite Universitaetsmedizin Berlin KöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Luspatercept
  • Sponsor:Universitaet Leipzig
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Technische Universitaet Dresden
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Lebrikizumab
  • Sponsor:Almirall S.A.

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Oberhausen

What the registry says about research in the country

01 Oncology Research

Innovative trials focusing on basal cell carcinoma and advanced breast cancer treatments. Studies evaluate novel therapeutic approaches including CDK4/6 inhibitors for metastatic breast cancer and new first-line treatments for skin cancer.

  • Advanced Basal Cell Carcinoma
  • Metastatic Breast Cancer
  • Colon Cancer Management

Research includes evaluation of treatment discontinuation strategies and disease control monitoring.

02 Dermatology and Immunology

Clinical research examining new treatments for atopic dermatitis, evaluating the effectiveness of targeted therapies in managing moderate-to-severe cases over a 24-week period.

  • Moderate-to-Severe Atopic Dermatitis
  • Immune System Responses
  • Long-term Disease Management

Focus on improving disease severity and symptom control in both adults and adolescents.

03 Hematology Studies

Advanced research in blood disorders, including studies on chronic lymphocytic leukemia and myelodysplastic syndromes. Trials evaluate combination therapies and novel treatment approaches.

  • High-Risk CLL Treatment
  • MDS Management
  • Anemia Interventions

Investigation of targeted therapies for better patient outcomes in blood disorders.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.